Freeport-McMoRan (FCX) counsel exercises options and sells 75,000 shares

Rhea-AI Filing Summary

Freeport-McMoRan EVP & General Counsel Douglas N. Currault II reported multiple equity transactions in February 2026. On February 9, 2026, he acquired 14,000 shares of Common Stock through a grant of restricted stock units and 20,625 shares through the vesting of performance share units, with 6,253 shares withheld to cover taxes on the PSU vesting.

On February 11, 2026, he exercised options to acquire 25,000 shares at $11.87 per share and 50,000 shares at $11.91 per share, then conducted an open-market sale of 75,000 shares at a weighted average price of $64.5175. Following these transactions, he directly beneficially owned 219,181 shares of Common Stock, which includes 57,166 RSUs.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Currault Douglas N. II

(Last) (First) (Middle)

4340 E. COTTON CENTER BLVD.

SUITE 110

(Street)

PHOENIX AZ 85040

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FREEPORT-MCMORAN INC [ FCX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		A(1)		14,000	A	$0	204,809	D
Common Stock	02/09/2026		A(2)		20,625	A	$0	225,434	D
Common Stock	02/09/2026		F(3)		6,253	D	$60.67	219,181	D
Common Stock	02/11/2026		M		25,000	A	$11.87	244,181	D
Common Stock	02/11/2026		M		50,000	A	$11.91	294,181	D
Common Stock	02/11/2026		S		75,000	D	$64.5175(5)	219,181(6)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (Right to Buy)	$11.87	02/11/2026		M			25,000	02/05/2020(4)	02/05/2029	Common Stock	25,000	$0	0	D
Options (Right to Buy)	$11.91	02/11/2026		M			50,000	02/06/2020(4)	02/06/2029	Common Stock	50,000	$0	0	D

Explanation of Responses:

1. Represents a grant of Common Stock Restricted Stock Units ("RSUs").

2. Shares acquired through the vesting of performance share units ("PSUs") granted on February 7, 2023.

3. Shares withheld to cover the taxes due upon the vesting of PSUs.

4. 33% exercisable on the date indicated and 33% exercisable on each of the next two anniversaries thereof.

5. The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $64.5100 - $64.5550. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

6. Amount beneficially owned includes 57,166 RSUs.

Remarks:

In addition to the awards reported herein, on February 9, 2026, the Reporting Person also received a grant of PSUs, which will be reflected on a Form 4 if and when such units vest. Vesting of the PSUs will be determined by the Issuer's average return on investment and relative TSR over the three-year performance period ending December 31, 2028.

	Kelly C. Simoneaux, on behalf of Douglas N. Currault II pursuant to a power of attorney	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did FCX executive Douglas N. Currault II report?

He reported equity awards, option exercises, and a share sale. On February 9, 2026, he received RSU and PSU-related shares, then on February 11, 2026, exercised stock options and sold 75,000 Common Stock shares in the open market.

How many Freeport-McMoRan (FCX) shares did the EVP sell in this Form 4?

He sold 75,000 shares of Common Stock. The shares were sold at a weighted average price of $64.5175, with individual sale prices ranging from $64.5100 to $64.5550, as detailed in the filing footnote.

What stock option exercises did the FCX EVP report in February 2026?

On February 11, 2026, he exercised options to acquire 25,000 shares at $11.87 and 50,000 shares at $11.91 per share. These options related to grants originally dated February 5, 2020 and February 6, 2020.

How many Freeport-McMoRan (FCX) shares does the EVP beneficially own after these transactions?

After the reported transactions, he beneficially owned 219,181 shares of Common Stock. This total includes 57,166 restricted stock units (RSUs), as specified in the explanatory footnotes to the Form 4.

What equity awards did the FCX EVP receive on February 9, 2026?

He received a grant of 14,000 shares of Common Stock through restricted stock units and 20,625 shares through vesting performance share units. An additional 6,253 shares were withheld to cover taxes due on the PSU vesting.

Are the February 11, 2026 FCX share dispositions tax-related or market sales?

On February 11, 2026, the 75,000-share disposition was an open-market sale. The tax-related disposition occurred earlier, when 6,253 shares were withheld on February 9, 2026 to satisfy taxes on vesting performance share units.